Western Blot: p38 [p Tyr182] Antibody [NB100-82097] - Analysis of extracts from Hela cells, treated with TNFa or calf intestinal phosphatase (CIP).
Immunohistochemistry: p38 [p Tyr182] Antibody [NB100-82097] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue, using P38 MAPK (phospho- Tyr182) antibody
Western Blot: p38 [p Tyr182] Antibody [NB100-82097] - Western blot analysis of extracts from NIH-3T3 (Lanes 1, 4, 7 and 10) and cos7 (Lanes 2, 5, 8 and 11 and K562 (Lanes 3, 6, 9 and 12) cells, untreated or treated with ...read more
Western Blot: p38 [p Tyr182] Antibody [NB100-82097] - Analysis of extracts from Hela cells untreated or treated with UV for the indicated times, using P38 MAPK(Phospho-Tyr182) antibody
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
PBS [pH 7.4] containing 150mM NaCl, and 50% glycerol (without Mg2+ and Ca2+)
0.02% Sodium Azide
Immunogen affinity purified
The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Read Publication using NB100-82097 in the following applications:
cytokine suppressive inflammatory drug binding protein
Cytokine suppressive inflammatory drug-binding protein
MAP kinase 14
MAP kinase MXI2
MAP kinase p38 alpha
mitogen-activated protein kinase 14
Mitogen-activated protein kinase p38 alpha
p38 MAP kinase
p38 mitogen activated protein kinase
stress-activated protein kinase 2A
p38 is a 38 kDa Stress Activated Protein Kinase / Map Kinase (SAPK / MAPK) that is fully activated by dual phosphorylation on threonine 180 and tyrosine 182, within the activation loop. p38 MAPK plays a critical role in the initiation of G2 delay after ultraviolet radiation; gene knock out studies have also revealed a critical role for p38 in cardiac remodeling. Downstream targets of p38 include the transcription factors ELK1 and ATF2 and the kinases MAPKAPK2 and MAPKAPK5. p38 MAPK plays a role in the production of IL6 and is thought to stabilize erythropoietin production during hypoxic stress.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.